Literature DB >> 28931915

Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses.

Catherine Okoi1, Suzanne T B Anderson2, Martin Antonio1,3,4, Sarah N Mulwa5, Florian Gehre1,6, Ifedayo M O Adetifa7,8,9.   

Abstract

Pulmonary non-tuberculous mycobacterial (NTM) disease epidemiology in sub-Saharan Africa is not as well described as for pulmonary tuberculosis. Earlier reviews of global NTM epidemiology only included subject-level data from one sub-Saharan Africa country. We systematically reviewed the literature and searched PubMed, Embase, Popline, OVID and Africa Wide Information for articles on prevalence and clinical relevance of NTM detection in pulmonary samples in sub-Saharan Africa. We applied the American Thoracic Society/Infectious Disease Society of America criteria to differentiate between colonisation and disease. Only 37 articles from 373 citations met our inclusion criteria. The prevalence of pulmonary NTM colonization was 7.5% (95% CI: 7.2%-7.8%), and 75.0% (2325 of 3096) occurred in males, 16.5% (512 of 3096) in those previously treated for tuberculosis and Mycobacterium avium complex predominated (27.7% [95% CI: 27.2-28.9%]). In seven eligible studies, 27.9% (266 of 952) of participants had pulmonary NTM disease and M. kansasii with a prevalence of 69.2% [95% CI: 63.2-74.7%] was the most common cause of pulmonary NTM disease. NTM species were unidentifiable in 29.2% [2,623 of 8,980] of isolates. In conclusion, pulmonary NTM disease is a neglected and emerging public health disease and enhanced surveillance is required.

Entities:  

Mesh:

Year:  2017        PMID: 28931915      PMCID: PMC5607231          DOI: 10.1038/s41598-017-12175-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  60 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Isolation of nontuberculous mycobacteria in Zambia: eight case reports.

Authors:  Patricia C A M Buijtels; Pieter L C Petit; Henri A Verbrugh; Alex van Belkum; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.

Authors:  N Martín-Casabona; A R Bahrmand; J Bennedsen; V Ostergaard Thomsen; M Curcio; M Fauville-Dufaux; K Feldman; M Havelkova; M L Katila; K Köksalan; M F Pereira; F Rodrigues; G E Pfyffer; F Portaels; J Rosselló Urgell; S Rüsch-Gerdes; E Tortoli; V Vincent; B Watt
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

Review 4.  Therapy of nontuberculous mycobacterial disease.

Authors:  David E Griffith
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

5.  Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia.

Authors:  M Jankovic; M Samarzija; I Sabol; M Jakopovic; V Katalinic Jankovic; L Zmak; B Ticac; A Marusic; M Obrovac; J van Ingen
Journal:  Int J Tuberc Lung Dis       Date:  2013-06       Impact factor: 2.373

6.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

Review 7.  Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.

Authors:  Brian A Kendall; Kevin L Winthrop
Journal:  Semin Respir Crit Care Med       Date:  2013-03-04       Impact factor: 3.119

8.  Mycobacterium xenopi pulmonary disease - epidemiology and clinical features in non-immunocompromised patients.

Authors:  Ante Marusić; Vera Katalinić-Janković; Sanja Popović-Grle; Mateja Janković; Ivica Mazuranić; Igor Puljić; Helga Sertić Milić
Journal:  J Infect       Date:  2009-02-05       Impact factor: 6.072

9.  Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

Authors:  Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot
Journal:  BMC Infect Dis       Date:  2011-11-05       Impact factor: 3.090

10.  Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis.

Authors:  Ana Roberta Fusco da Costa; Joseph O Falkinham; Maria Luiza Lopes; Adriana Rodrigues Barretto; João Soares Felicio; Lúcia Helena Messias Sales; Jeann Ricardo da Costa Bahia; Emilyn Costa Conceição; Karla Valéria Batista Lima
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18
View more
  13 in total

1.  Clofazimine for the Treatment of Mycobacterium kansasii.

Authors:  Shashikant Srivastava; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 2.  Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.

Authors:  Javeed A Shah; Cecilia S Lindestam Arlehamn; David J Horne; Alessandro Sette; Thomas R Hawn
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

3.  Prevalence of non-tuberculous mycobacteria among previously treated TB patients in the Gulf of Guinea, Africa.

Authors:  B D Thumamo Pokam; D Yeboah-Manu; S Ofori; P W Guemdjom; P M Teyim; L Lawson; D Amiteye; N Y Yhiler; I C Djuikoue; A E Asuquo
Journal:  IJID Reg       Date:  2022-05-14

4.  Culture-Independent PCR Detection and Differentiation of Mycobacteria spp. in Antemortem Respiratory Samples from African Elephants (Loxodonta Africana) and Rhinoceros (Ceratotherium Simum, Diceros Bicornis) in South Africa.

Authors:  Wynand J Goosen; Charlene Clarke; Léanie Kleynhans; Tanya J Kerr; Peter Buss; Michele A Miller
Journal:  Pathogens       Date:  2022-06-20

5.  Molecular Identification, and Characterization of Mycobacterium kansasii Strains Isolated from Four Tuberculosis Regional Reference Laboratories in Iran During 2016-2018.

Authors:  Azar Dokht Khosravi; Bahareh Asban; Mohammad Hashemzadeh; Roohangiz Nashibi
Journal:  Infect Drug Resist       Date:  2020-07-07       Impact factor: 4.003

Review 6.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

Review 7.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

8.  Machine Learning-Based Differentiation of Nontuberculous Mycobacteria Lung Disease and Pulmonary Tuberculosis Using CT Images.

Authors:  Zhiheng Xing; Wenlong Ding; Shuo Zhang; Lingshan Zhong; Li Wang; Jigang Wang; Kai Wang; Yi Xie; Xinqian Zhao; Nan Li; Zhaoxiang Ye
Journal:  Biomed Res Int       Date:  2020-09-29       Impact factor: 3.411

9.  Mycobacterium szulgai cavitary lung disease progression over a three year period - A case report.

Authors:  Michael C Croix; Sonal S Munsiff
Journal:  IDCases       Date:  2022-01-05

10.  Activation-Induced Marker Expression Identifies Mycobacterium tuberculosis-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent Tuberculosis.

Authors:  Morgan S Barham; Wendy E Whatney; Jeremiah Khayumbi; Joshua Ongalo; Loren E Sasser; Angela Campbell; Meghan Franczek; Mbuyi Madeleine Kabongo; Samuel G Ouma; Felix Odhiambo Hayara; Neel R Gandhi; Cheryl L Day
Journal:  Immunohorizons       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.